Related Experiment Video
Updated: Jun 25, 2026

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques
Published on: June 1, 2016
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation
Michael Ewers1,2, Gloria Biechele3, Marc Suárez-Calvet4,5,6
1Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.
Abstract:
Microglia activation is the brain's major immune response to amyloid plaques in Alzheimer's disease (AD). Both cerebrospinal fluid (CSF) levels of soluble TREM2 (sTREM2), a biomarker of microglia activation, and microglia PET are increased in AD; however, whether an increase in these biomarkers is associated with reduced amyloid-beta (Aβ) accumulation remains unclear. To address this question, we pursued a two-pronged translational approach. Firstly, in non-demented and demented individuals, we tested CSF sTREM2 at baseline to predict (i) amyloid PET changes over ∼2 years and (ii) tau PET cross-sectionally assessed in a subset of patients. We found higher CSF sTREM2 associated with attenuated amyloid PET increase and lower tau PET. Secondly, in the AppNL-G-F mouse model of amyloidosis, we studied baseline 18 F-GE180 microglia PET and longitudinal amyloid PET to test the microglia vs. Aβ association, without any confounding co-pathologies often present in AD patients. Higher microglia PET at age 5 months was associated with a slower amyloid PET increase between ages 5-to-10 months. In conclusion, higher microglia activation as determined by CSF sTREM2 or microglia PET shows protective effects on subsequent amyloid accumulation.
Insights
Increased microglia activation, measured by CSF sTREM2 or PET scans, appears to protect against amyloid-beta accumulation in Alzheimer's disease (AD). This suggests a beneficial role for these immune responses in AD progression.
Area of Science:
- Neuroscience
- Immunology
- Neurology
Background:
- Microglia activation is a key brain immune response in Alzheimer's disease (AD), linked to amyloid plaques.
- Biomarkers like soluble TREM2 (sTREM2) in CSF and microglia PET scans are elevated in AD.
- The relationship between increased microglia activation and reduced amyloid-beta (Aβ) accumulation is not fully understood.
Purpose of the Study:
- To investigate whether elevated microglia activation biomarkers predict reduced amyloid-beta accumulation in Alzheimer's disease.
- To explore the association between cerebrospinal fluid sTREM2 levels and longitudinal changes in amyloid PET.
- To examine the correlation between microglia PET imaging and amyloid PET progression in a mouse model of amyloidosis.
Main Methods:
- Human study: Measured CSF sTREM2 to predict longitudinal amyloid PET changes and cross-sectional tau PET in non-demented and demented individuals.
- Animal study: Utilized the AppNL-GF mouse model to assess baseline 18F-GE180 microglia PET and longitudinal amyloid PET.
- Controlled for confounding pathologies in the mouse model to isolate the microglia-amyloid relationship.
Main Results:
- In humans, higher baseline CSF sTREM2 levels correlated with attenuated increases in amyloid PET over two years and lower tau PET.
- In mice, higher baseline microglia PET at 5 months was associated with a slower rate of amyloid PET increase between 5 and 10 months.
- These findings demonstrate a consistent protective association between heightened microglia activation and reduced subsequent amyloid accumulation.
Conclusions:
- Elevated microglia activation, indicated by CSF sTREM2 or microglia PET, demonstrates a protective effect against subsequent amyloid accumulation.
- This suggests that targeting microglia activation could be a potential therapeutic strategy for Alzheimer's disease.
- The study provides translational evidence from human and animal models supporting a beneficial role for microglia in mitigating amyloid pathology.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
06:22A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
Published on: September 3, 2021